blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2707505

EP2707505 - SPECTRAL IMAGING FOR MEASUREMENT OF NUCLEAR PATHOLOGY FEATURES IN CANCER CELLS PREPARED FOR IN SITU ANALYSIS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  14.04.2017
Database last updated on 05.10.2024
Most recent event   Tooltip06.03.2020Lapse of the patent in a contracting state
New state(s): TR		published on 08.04.2020  [2020/15]
Applicant(s)For all designated states
Ventana Medical Systems, Inc.
1910 Innovation Park Drive
Tucson, AZ 85755 / US
For all designated states
Cornell University
Cornell Center for Technology Enterprise
& Commercialization
395 Pine Tree Road
Suite 310
Ithaca, NY 14850 / US
[N/P]
Former [2016/01]For all designated states
Ventana Medical Systems, Inc.
1910 Innovation Park Drive
Tucson AZ 85755 / US
For all designated states
Cornell University
Cornell Center for Technology Enterprise
& Commercialization
395 Pine Tree Road
Suite 310
Ithaca, NY 14850 / US
Former [2014/12]For all designated states
Ventana Medical Systems, Inc.
1910 E. Innovation Park Drive
Tucson, Arizona 85755 / US
For all designated states
Cornell University
Cornell Center for Technology Enterprise
& Commercialization
395 Pine Tree Road
Suite 310
Ithaca, NY 14850 / US
Inventor(s)01 / DEMICHELIS, Francesca
223 W. 14th Stree, Apt 4B
New York New York 10011 / US
02 / GARSHA, Karl
15058 Theodore Roosevelt Way
Sahuarita Arizona 85629 / US
03 / MILLER, Phillip C
1821 Calle Del Vaso
Tucson Arizona 85737 / US
04 / NAGLE, Ray B
2027 E. Helen Street
Tucson Arizona 85719 / US
05 / OTTER, Michael
11809 North Mountain Laurel Place
Tucson Arizona 85737 / US
06 / PESTANO, Gary Anthony
2650 Ginny Way
Lafayette CO 80026 / US
07 / RUBIN, Mark A.
520 W. 23rd Street (10A)
New York New York 10011 / US
 [2016/23]
Former [2014/12]01 / DEMICHELIS, Francesca
223 W. 14th Stree, Apt 4B
New York New York 10011 / US
02 / GARSHA, Karl
15058 Theodore Roosevelt Way
Sahuarita Arizona 85629 / US
03 / MILLER, Phillip C
1821 Calle Del Vaso
Tucson Arizona 85737 / US
04 / NAGLE, Ray B
2027 E. Helen Street
Tucson Arizona 85719 / US
05 / OTTER, Michael
11809 North Mountain Laurel Place
Tucson Arizona 85737 / US
06 / PESTANO, Gary Anthony
11630 North Dragon Springs Drive
Oro Valley Arizona 85737 / US
07 / RUBIN, Mark A.
520 W. 23rd Street (10A)
New York New York 10011 / US
Representative(s)Burger, Alexander
Roche Diagnostics GmbH
Patentabteilung
Nonnenwald 2
82377 Penzberg / DE
[N/P]
Former [2014/12]Burger, Alexander
Roche Diagnostics GmbH Patent Department (LPP.....6164) P.O.Box 11 52
82372 Penzberg / DE
Application number, filing date12725639.407.05.2012
[2016/23]
WO2012EP58356
Priority number, dateUS201161483928P09.05.2011         Original published format: US 201161483928 P
[2014/12]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2012152747
Date:15.11.2012
Language:EN
[2012/46]
Type: A2 Application without search report 
No.:EP2707505
Date:19.03.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 15.11.2012 takes the place of the publication of the European patent application.
[2014/12]
Type: B1 Patent specification 
No.:EP2707505
Date:08.06.2016
Language:EN
[2016/23]
Search report(s)International search report - published on:EP24.01.2013
ClassificationIPC:C12Q1/68, G01N33/574
[2014/12]
CPC:
C12Q1/6886 (EP,US); H01H35/146 (EP,CN,US); C12Q1/6841 (EP,US);
G01N33/57407 (EP,US); G16B20/00 (EP,CN,US); G16B20/20 (EP,CN,US);
H01M50/572 (US); H01M50/578 (EP,CN,US); H01M50/579 (EP,CN,US);
H01M50/581 (EP,CN,US); C12Q2600/156 (EP,US); H01M2220/20 (EP,CN,US);
Y02E60/10 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/12]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:SPEKTRALBILDGEBUNG ZUR MESSUNG VON NUKLEARPATHOLOGISCHEN MERKMALEN IN KREBSZELLEN ZUR IN-SITU-ANALYSE[2014/12]
English:SPECTRAL IMAGING FOR MEASUREMENT OF NUCLEAR PATHOLOGY FEATURES IN CANCER CELLS PREPARED FOR IN SITU ANALYSIS[2014/12]
French:IMAGERIE SPECTRALE POUR LA MESURE DE CARACTÉRISTIQUES PATHOLOGIQUES DES NOYAUX DANS DES CELLULES CANCÉREUSES PRÉPARÉES POUR UNE ANALYSE IN-SITU[2014/12]
Entry into regional phase09.12.2013National basic fee paid 
09.12.2013Designation fee(s) paid 
09.12.2013Examination fee paid 
Examination procedure15.11.2013Amendment by applicant (claims and/or description)
09.12.2013Examination requested  [2014/12]
18.12.2015Communication of intention to grant the patent
26.04.2016Fee for grant paid
26.04.2016Fee for publishing/printing paid
26.04.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  18.12.2015
Opposition(s)09.03.2017No opposition filed within time limit [2017/20]
Fees paidRenewal fee
26.03.2014Renewal fee patent year 03
07.05.2015Renewal fee patent year 04
30.03.2016Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU07.05.2012
AL08.06.2016
AT08.06.2016
BE08.06.2016
BG08.06.2016
CY08.06.2016
CZ08.06.2016
EE08.06.2016
FI08.06.2016
HR08.06.2016
LT08.06.2016
LV08.06.2016
MC08.06.2016
MK08.06.2016
NL08.06.2016
PL08.06.2016
RO08.06.2016
RS08.06.2016
SE08.06.2016
SI08.06.2016
SK08.06.2016
SM08.06.2016
TR08.06.2016
NO08.09.2016
GR09.09.2016
IS08.10.2016
PT10.10.2016
[2020/15]
Former [2019/51]HU07.05.2012
AL08.06.2016
AT08.06.2016
BE08.06.2016
BG08.06.2016
CY08.06.2016
CZ08.06.2016
EE08.06.2016
FI08.06.2016
HR08.06.2016
LT08.06.2016
LV08.06.2016
MC08.06.2016
MK08.06.2016
NL08.06.2016
PL08.06.2016
RO08.06.2016
RS08.06.2016
SE08.06.2016
SI08.06.2016
SK08.06.2016
SM08.06.2016
NO08.09.2016
GR09.09.2016
IS08.10.2016
PT10.10.2016
Former [2019/46]HU07.05.2012
AL08.06.2016
AT08.06.2016
BE08.06.2016
BG08.06.2016
CY08.06.2016
CZ08.06.2016
EE08.06.2016
FI08.06.2016
HR08.06.2016
LT08.06.2016
LV08.06.2016
MC08.06.2016
NL08.06.2016
PL08.06.2016
RO08.06.2016
RS08.06.2016
SE08.06.2016
SI08.06.2016
SK08.06.2016
SM08.06.2016
NO08.09.2016
GR09.09.2016
IS08.10.2016
PT10.10.2016
Former [2019/39]HU07.05.2012
AL08.06.2016
AT08.06.2016
BE08.06.2016
BG08.06.2016
CZ08.06.2016
EE08.06.2016
FI08.06.2016
HR08.06.2016
LT08.06.2016
LV08.06.2016
MC08.06.2016
NL08.06.2016
PL08.06.2016
RO08.06.2016
RS08.06.2016
SE08.06.2016
SI08.06.2016
SK08.06.2016
SM08.06.2016
NO08.09.2016
GR09.09.2016
IS08.10.2016
PT10.10.2016
Former [2019/31]HU07.05.2012
AL08.06.2016
AT08.06.2016
BE08.06.2016
CZ08.06.2016
EE08.06.2016
FI08.06.2016
HR08.06.2016
LT08.06.2016
LV08.06.2016
MC08.06.2016
NL08.06.2016
PL08.06.2016
RO08.06.2016
RS08.06.2016
SE08.06.2016
SI08.06.2016
SK08.06.2016
SM08.06.2016
NO08.09.2016
GR09.09.2016
IS08.10.2016
PT10.10.2016
Former [2018/46]AL08.06.2016
AT08.06.2016
BE08.06.2016
CZ08.06.2016
EE08.06.2016
FI08.06.2016
HR08.06.2016
LT08.06.2016
LV08.06.2016
MC08.06.2016
NL08.06.2016
PL08.06.2016
RO08.06.2016
RS08.06.2016
SE08.06.2016
SI08.06.2016
SK08.06.2016
SM08.06.2016
NO08.09.2016
GR09.09.2016
IS08.10.2016
PT10.10.2016
Former [2018/06]AT08.06.2016
BE08.06.2016
CZ08.06.2016
EE08.06.2016
FI08.06.2016
HR08.06.2016
LT08.06.2016
LV08.06.2016
MC08.06.2016
NL08.06.2016
PL08.06.2016
RO08.06.2016
RS08.06.2016
SE08.06.2016
SI08.06.2016
SK08.06.2016
SM08.06.2016
NO08.09.2016
GR09.09.2016
IS08.10.2016
PT10.10.2016
Former [2017/37]AT08.06.2016
BE08.06.2016
CZ08.06.2016
EE08.06.2016
FI08.06.2016
HR08.06.2016
LT08.06.2016
LV08.06.2016
NL08.06.2016
PL08.06.2016
RO08.06.2016
RS08.06.2016
SE08.06.2016
SI08.06.2016
SK08.06.2016
SM08.06.2016
NO08.09.2016
GR09.09.2016
IS08.10.2016
PT10.10.2016
Former [2017/11]AT08.06.2016
BE08.06.2016
CZ08.06.2016
EE08.06.2016
FI08.06.2016
HR08.06.2016
LT08.06.2016
LV08.06.2016
NL08.06.2016
PL08.06.2016
RO08.06.2016
RS08.06.2016
SE08.06.2016
SK08.06.2016
SM08.06.2016
NO08.09.2016
GR09.09.2016
IS08.10.2016
PT10.10.2016
Former [2017/10]BE08.06.2016
CZ08.06.2016
EE08.06.2016
FI08.06.2016
HR08.06.2016
LT08.06.2016
LV08.06.2016
NL08.06.2016
PL08.06.2016
RO08.06.2016
RS08.06.2016
SE08.06.2016
SK08.06.2016
NO08.09.2016
GR09.09.2016
IS08.10.2016
Former [2017/09]CZ08.06.2016
EE08.06.2016
FI08.06.2016
HR08.06.2016
LT08.06.2016
LV08.06.2016
NL08.06.2016
RO08.06.2016
RS08.06.2016
SE08.06.2016
NO08.09.2016
GR09.09.2016
Former [2016/52]FI08.06.2016
HR08.06.2016
LT08.06.2016
LV08.06.2016
NL08.06.2016
RS08.06.2016
SE08.06.2016
NO08.09.2016
GR09.09.2016
Former [2016/51]FI08.06.2016
HR08.06.2016
LT08.06.2016
LV08.06.2016
RS08.06.2016
NO08.09.2016
GR09.09.2016
Former [2016/50]FI08.06.2016
HR08.06.2016
LT08.06.2016
LV08.06.2016
RS08.06.2016
NO08.09.2016
Former [2016/49]FI08.06.2016
LT08.06.2016
NO08.09.2016
Former [2016/46]LT08.06.2016
NO08.09.2016
Cited inInternational search[XI]US5989811  (VELTRI ROBERT W [US], et al) [X] 1,4,7,10-12 * example xiii *[I] 2,3,5,8,9
ExaminationUS6025128
 US2010317002
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.